• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助治疗后行食管切除术的食管鳞状细胞癌患者控制营养状况评分的预后价值——一项回顾性研究

The prognostic value of controlling nutritional status score on esophageal squamous cell carcinoma patients with neoadjuvant therapy followed by esophagectomy-a retrospective research.

作者信息

Fang Pinhao, Zhou Jianfeng, Liang Zhiwen, Yang Yushang, Luan Siyuan, Xiao Xin, Li Xiaokun, Shang Qixin, Zhang Hanlu, Zeng Xiaoxi, Yuan Yong

机构信息

Department of Thoracic Surgery, Med+X Center for Informatics, West China Hospital, Sichuan University, Chengdu, China.

Biomedical Big Data Center of West China Hospital, Med+X Center for Informatics, Sichuan University, Chengdu, China.

出版信息

J Thorac Dis. 2024 Jul 30;16(7):4460-4473. doi: 10.21037/jtd-24-187. Epub 2024 Jul 26.

DOI:10.21037/jtd-24-187
PMID:39144298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11320261/
Abstract

BACKGROUND

A variety of nutritional evaluation parameters has been documented as prognostic indicators in some malignancies. However, the prognostic significance of the controlling nutritional status (CONUT) score, as one of these nutritional indices, in patients with esophageal squamous cell carcinoma (ESCC) remains unclear and warrants investigation. Our study sought to elucidate the prognostic value of this nutritional index in ESCC patients who underwent neoadjuvant therapy followed by esophagectomy.

METHODS

This retrospective study encompassed 314 patients diagnosed with ESCC who underwent neoadjuvant therapy followed by esophagectomy at West China Hospital of Sichuan University between August 2016 and August 2021. CONUT scores were computed at two specific time points: prior to neoadjuvant therapy initiation and before surgery, utilizing serum albumin, total lymphocyte, and cholesterol levels of ESCC patients. Furthermore, the delta CONUT (ΔCONUT) score was derived by subtracting the preoperative CONUT score from the pretreatment CONUT score. The associations between CONUT scores and various survival outcomes were evaluated using Kaplan-Meier methods and Cox regression analysis.

RESULTS

Patients with a high preoperative CONUT score demonstrated a higher postoperative complication rate [odds ratio (OR) =2.009, 95% confidence interval (CI): 1.150-3.510, P=0.01] compared to those in the low CONUT group. Multivariate analysis revealed that a ΔCONUT score ≥0 served as an independent negative prognostic indicator for increased postoperative complications (OR =3.008, 95% CI: 1.509-5.999, P=0.002) and poorer overall survival [hazard ratio (HR) =2.388, 95% CI: 1.052-5.422, P=0.04] in ESCC patients who underwent neoadjuvant therapy combined with esophagectomy.

CONCLUSIONS

A high preoperative CONUT score and a ΔCONUT score ≥0 were indicative of a poor prognostic nutritional status in ESCC patients who had undergone neoadjuvant therapy followed by esophagectomy.

摘要

背景

多种营养评估参数已被记录为某些恶性肿瘤的预后指标。然而,作为这些营养指标之一的控制营养状况(CONUT)评分在食管鳞状细胞癌(ESCC)患者中的预后意义仍不明确,值得研究。我们的研究旨在阐明该营养指标在接受新辅助治疗后行食管切除术的ESCC患者中的预后价值。

方法

这项回顾性研究纳入了2016年8月至2021年8月期间在四川大学华西医院诊断为ESCC并接受新辅助治疗后行食管切除术的314例患者。CONUT评分在两个特定时间点计算:新辅助治疗开始前和手术前,利用ESCC患者的血清白蛋白、总淋巴细胞和胆固醇水平。此外,通过术前CONUT评分减去治疗前CONUT评分得出ΔCONUT评分。使用Kaplan-Meier方法和Cox回归分析评估CONUT评分与各种生存结局之间的关联。

结果

与低CONUT组相比,术前CONUT评分高的患者术后并发症发生率更高[比值比(OR)=2.009,95%置信区间(CI):1.150-3.510,P=0.01]。多变量分析显示,ΔCONUT评分≥0是接受新辅助治疗联合食管切除术的ESCC患者术后并发症增加(OR =3.008,95%CI:1.509-5.999,P=0.002)和总生存期较差[风险比(HR)=2.388,95%CI:1.052-5.422,P=0.04]的独立阴性预后指标。

结论

术前CONUT评分高和ΔCONUT评分≥0表明接受新辅助治疗后行食管切除术的ESCC患者预后营养状况较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/422a/11320261/555710734d10/jtd-16-07-4460-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/422a/11320261/90843a24e31f/jtd-16-07-4460-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/422a/11320261/8af9049d3402/jtd-16-07-4460-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/422a/11320261/555710734d10/jtd-16-07-4460-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/422a/11320261/90843a24e31f/jtd-16-07-4460-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/422a/11320261/8af9049d3402/jtd-16-07-4460-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/422a/11320261/555710734d10/jtd-16-07-4460-f3.jpg

相似文献

1
The prognostic value of controlling nutritional status score on esophageal squamous cell carcinoma patients with neoadjuvant therapy followed by esophagectomy-a retrospective research.新辅助治疗后行食管切除术的食管鳞状细胞癌患者控制营养状况评分的预后价值——一项回顾性研究
J Thorac Dis. 2024 Jul 30;16(7):4460-4473. doi: 10.21037/jtd-24-187. Epub 2024 Jul 26.
2
Controlling Nutritional Status Score Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma: Optimal Timing of Evaluation of Patients Undergoing Neoadjuvant Treatment.控制营养状况评分可作为食管鳞状细胞癌的预后指标:新辅助治疗患者评估的最佳时机
World J Surg. 2023 Jan;47(1):217-226. doi: 10.1007/s00268-022-06773-w. Epub 2022 Oct 5.
3
The usefulness of pretreatment controlling nutritional status score for predicting recurrence in patients with esophageal squamous cell carcinoma undergoing neoadjuvant immunochemotherapy: A real-world study.新辅助免疫化疗治疗食管鳞癌患者的预处理控制营养状况评分对预测复发的作用:一项真实世界研究。
Front Immunol. 2022 Nov 24;13:1015365. doi: 10.3389/fimmu.2022.1015365. eCollection 2022.
4
The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.术前控制营养状况(CONUT)评分是可切除胸段食管鳞状细胞癌患者的独立预后因素:一项回顾性研究结果
BMC Cancer. 2016 Sep 6;16(1):722. doi: 10.1186/s12885-016-2696-0.
5
The impact of geriatric nutritional risk index on esophageal squamous cell carcinoma patients with neoadjuvant therapy followed by esophagectomy.老年营养风险指数对接受新辅助治疗后行食管切除术的食管鳞状细胞癌患者的影响。
Front Nutr. 2022 Oct 20;9:983038. doi: 10.3389/fnut.2022.983038. eCollection 2022.
6
Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy.老年局部晚期食管鳞癌患者接受根治性放化疗或单纯放疗的术前营养风险因素的预后价值。
BMC Cancer. 2023 Jun 28;23(1):597. doi: 10.1186/s12885-023-11044-5.
7
Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.多中心研究控制营养状况(CONUT)评分作为 HIV 相关肾细胞癌患者的预后因素。
Front Immunol. 2021 Nov 30;12:778746. doi: 10.3389/fimmu.2021.778746. eCollection 2021.
8
Comparison of Preoperative Nutritional Indexes for Outcomes after Primary Esophageal Surgery for Esophageal Squamous Cell Carcinoma.比较原发性食管鳞癌手术前后营养指标与预后的关系。
Nutrients. 2021 Nov 15;13(11):4086. doi: 10.3390/nu13114086.
9
The Predictive Values of Pretreatment Controlling Nutritional Status (CONUT) Score in Estimating Short- and Long-term Outcomes for Patients with Gastric Cancer Treated with Neoadjuvant Chemotherapy and Curative Gastrectomy.治疗前控制营养状况(CONUT)评分对接受新辅助化疗和根治性胃切除术的胃癌患者短期和长期预后的预测价值
J Gastric Cancer. 2021 Jun;21(2):155-168. doi: 10.5230/jgc.2021.21.e14. Epub 2021 Jun 18.
10
Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma.控制营养状况评分对肺鳞状细胞癌切除术后的预后影响
J Thorac Dis. 2017 Sep;9(9):2942-2951. doi: 10.21037/jtd.2017.07.108.

引用本文的文献

1
The investigation of factors influencing the prognostic nutritional index in patients with esophageal cancer-a cross-sectional study.影响食管癌患者预后营养指数的因素调查——一项横断面研究
J Thorac Dis. 2025 Jul 31;17(7):5065-5077. doi: 10.21037/jtd-2025-120. Epub 2025 Jul 17.
2
Prognostic and clinicopathological value of the controlling nutritional status score in patients with multiple myeloma: a meta-analysis.控制营养状况评分在多发性骨髓瘤患者中的预后及临床病理价值:一项荟萃分析
Front Oncol. 2025 Mar 18;15:1517223. doi: 10.3389/fonc.2025.1517223. eCollection 2025.

本文引用的文献

1
Spatiotemporal Patterns of Esophageal Cancer Burden Attributable to Behavioral, Metabolic, and Dietary Risk Factors From 1990 to 2019: Longitudinal Observational Study.1990 年至 2019 年行为、代谢和饮食风险因素导致的食管癌负担的时空模式:纵向观察研究。
JMIR Public Health Surveill. 2023 Oct 6;9:e46051. doi: 10.2196/46051.
2
Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score.比较化疗联合免疫治疗与单纯化疗在晚期胆道癌中的疗效,并构建基于炎症指数和控制营养状况评分的生存预测列线图。
Cancer Immunol Immunother. 2023 Nov;72(11):3635-3649. doi: 10.1007/s00262-023-03513-4. Epub 2023 Sep 5.
3
Effect of sequential vs. non-sequential early enteral nutrition therapy on nutritional status, recovery, and quality of life of patients with esophageal cancer.序贯与非序贯早期肠内营养治疗对食管癌患者营养状况、康复和生活质量的影响。
Eur Rev Med Pharmacol Sci. 2023 Aug;27(16):7590-7596. doi: 10.26355/eurrev_202308_33411.
4
Mechanisms of esophageal cancer metastasis and treatment progress.食管癌转移的机制与治疗进展。
Front Immunol. 2023 Jun 8;14:1206504. doi: 10.3389/fimmu.2023.1206504. eCollection 2023.
5
Nasogastric tube feeding improves nutritional status and physical state in esophageal cancer patients during chemoradiotherapy: a retrospective study.鼻胃管喂养可改善食管癌患者放化疗期间的营养状况和身体状况:一项回顾性研究。
Support Care Cancer. 2023 May 17;31(6):341. doi: 10.1007/s00520-023-07780-w.
6
The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis.肌肉减少症在食管癌中的预后价值:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):3-16. doi: 10.1002/jcsm.13126. Epub 2022 Nov 22.
7
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial.新辅助放化疗对比新辅助化疗后行微创食管切除术治疗局部进展期食管鳞癌:一项前瞻性多中心随机临床试验。
Ann Oncol. 2023 Feb;34(2):163-172. doi: 10.1016/j.annonc.2022.10.508. Epub 2022 Nov 15.
8
The impact of geriatric nutritional risk index on esophageal squamous cell carcinoma patients with neoadjuvant therapy followed by esophagectomy.老年营养风险指数对接受新辅助治疗后行食管切除术的食管鳞状细胞癌患者的影响。
Front Nutr. 2022 Oct 20;9:983038. doi: 10.3389/fnut.2022.983038. eCollection 2022.
9
[Nutritional supportive care in the course of patients with esophagogastric cancers].[食管癌和胃癌患者病程中的营养支持治疗]
Bull Cancer. 2023 May;110(5):540-551. doi: 10.1016/j.bulcan.2022.08.007. Epub 2022 Oct 4.
10
Esophageal cancer in China: Practice and research in the new era.中国食管癌:新时代的实践与研究。
Int J Cancer. 2023 May 1;152(9):1741-1751. doi: 10.1002/ijc.34301. Epub 2022 Oct 5.